Scholarly Index
Emre Aldinc
Alnylam Pharmaceuticals (United States); 587 total citations; 41 total publications; best world rank #177
Alnylam Pharmaceuticals (United States)
587Total citations
41Total publications
12H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Amyloidosis: Diagnosis, Treatment, Outcomes | 2021-2025 | 276 | US 90 | 90.34 |
| Parathyroid Disorders and Treatments | 2021-2025 | 764 | US 195 | 81.76 |
| Dermatological and Skeletal Disorders | 2021-2025 | 177 | US 46 | 74.88 |
| Protein Kinase Regulation and GTPase Signaling | 2021-2025 | 502 | US 219 | 55.68 |